Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 9;9(48):28241-28247.
doi: 10.1039/c9ra05797h. eCollection 2019 Sep 3.

Synthesis of a 1,2- cis-indoxyl galactoside as a chromogenic glycosidase substrate

Affiliations

Synthesis of a 1,2- cis-indoxyl galactoside as a chromogenic glycosidase substrate

Sakuto Nagata et al. RSC Adv. .

Abstract

A synthetically challenging 1,2-cis-indoxyl galactoside, X-α-galactoside, was first prepared in this study using a cyclic ketone indoxyl acceptor and a glycosyl trichloroacetimidate donor to produce an enol glycoside and a 4,6-O-di-tert-butylsilylene-protected galactosyl donor to complete the synthesis. The target compound shows enzyme activity in the presence of α-galactosidase.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1. Using indoxyl glycosides to detect glycosidase activity.
Fig. 2
Fig. 2. Examples of the successful formation of 1,2-trans-indoxyl glycosides via (A) under basic conditions and (B) under acidic conditions. TBAHS: tetrabutylammonium hydrogen sulfate; NIS: N-iodosuccinimide.
Fig. 3
Fig. 3. X-α-galactoside, the target molecule in this study. X = 5-bromo-4-chloro-3-indoxyl.
Scheme 1
Scheme 1. Glycosylation of indoxyl 7 using DTBS-protected Gal thioglycoside donor 11. Reagents and conditions: (a) DTBS(OTf)2, Py, r.t.; Ac2O, r.t., 97% (2 steps in one-pot fashion).
Scheme 2
Scheme 2. The successful conditions for the stereoselective glycosylation of cyclic ketone derivative 14 using Gal trichloroacetimidate donor 13 reported by Liu et al.
Scheme 3
Scheme 3. Global deprotection of fully protected X-α-Gal.
Fig. 4
Fig. 4. Monitoring of α-galactosidase activity using the synthesized X-α-Gal compound.

References

    1. Kiernan J. A. Biotech. Histochem. 2007;82:73–103. doi: 10.1080/10520290701375278. - DOI - PubMed
    1. Barrnett R. J. Seligman A. M. Science. 1951;114:579–582. doi: 10.1126/science.114.2970.579. - DOI - PubMed
    1. Saito S. Sumita S. Kanda Y. Sasaki Y. Tetrahedron Lett. 1992;33:7381–7384. doi: 10.1016/S0040-4039(00)60193-4. - DOI
    2. Saito S. Sumita S. Kanda Y. Sasaki Y. Chem. Pharm. Bull. 1994;42:1016–1027. doi: 10.1248/cpb.42.1016. - DOI - PubMed
    1. For review see:

    2. Böttcher S. Thiem J. Trends Carbohydr. Res. 2014;6:1–10.
    3. and references therein

    1. N-Acetyl-indoxyl acceptor is more likely present in the keto form in non-polar and aprotic solvents, which was confirmed in 1H NMR spectrum measured in this study (see ESI†)